Company Profile

95% of corneal blindness is either avoidable or treatable. EyeDea Medical's founders suggest that by creating impactful solutions for eye banks and corneal surgeons around the world, they plan drastically to reduce the over 25 MM patients that are experiencing needless blindness. Principals of the firm have developed a single-use graft preparation system that is designed explicitly to assist in corneal transplants. The company's system effectively simplifies corneal tissue processing - having the effect both of improving yields and expanding the donor pool while at the same time maintaining high-quality grafts for transplants. This combination of factors serves to enable eye banks to reduce costs whole also empowering capacity and efficacy.